Evidence that phosphorylation by the mitotic kinase Cdk1 promotes ICER monoubiquitination and nuclear delocalization

Exp Cell Res. 2011 Oct 15;317(17):2490-502. doi: 10.1016/j.yexcr.2011.07.001. Epub 2011 Jul 13.

Abstract

In contrast to normal prostatic cells, the transcriptional repressor Inducible cAMP Early Repressor (ICER) is undetected in the nuclei of prostate cancer cells. The molecular mechanisms for ICER abnormal expression in prostate cancer cells remained largely unknown. In this report data is presented demonstrating that ICER is phosphorylated by the mitotic kinase cdk1. Phosphorylation of ICER on a discrete residue targeted ICER to be monoubiquitinated. Different from unphosphorylated, phosphorylated and polyubiquitinated ICER, monoubiquitinated ICER was found to be cytosolic. Taken together, these results hinted on a mechanism for the observed abnormal subcellular localization of ICER in human prostate tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CDC2 Protein Kinase / metabolism*
  • Cell Nucleus / metabolism*
  • Cyclic AMP Response Element Modulator / metabolism*
  • Cytosol / chemistry
  • Cytosol / metabolism
  • HeLa Cells
  • Humans
  • Male
  • Mitosis
  • Phosphorylation
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Rats
  • Tumor Cells, Cultured
  • Ubiquitination*

Substances

  • CREM protein, human
  • Cyclic AMP Response Element Modulator
  • CDC2 Protein Kinase